Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 06.05.2024 1 BMC Cancer 1 Br J Cancer 4 Gynecol Oncol 2 Int J Cancer 1 Int J Gynaecol Obstet 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. XIE W, Zhang L, Shen J, Lai F, et al
   Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
   BMC Cancer. 2024;24:551.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. HERMAN L, Amo A, Legois B, Di Carlo C, et al
   A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
   Br J Cancer. 2024;130:1453-1462.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

3. HOLTZMAN S, McCarthy L, Estevez SL, Lee JA, et al
   Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors.
   Gynecol Oncol. 2024;186:176-181.
   PubMed         Abstract available
   
   
4. SMITH AJB, O'Brien C, Haggerty A, Ko EM, et al
   "Having cancer is very expensive": A qualitative study of patients with ovarian cancer and PARP inhibitor treatment.
   Gynecol Oncol. 2024;186:170-175.
   PubMed         Abstract available
   
   
5. CHALIF J, Chambers LM, Yao M, Kuznicki M, et al
   Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection.
   Gynecol Oncol. 2024;186:161-169.
   PubMed         Abstract available
   
   
6. ALGERA MD, van Driel WJ, Slangen BFM, Wouters MWJM, et al
   Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit.
   Gynecol Oncol. 2024;186:144-153.
   PubMed         Abstract available
   
   

   
   Int J Cancer

7. OBERMAYR E, Mohr T, Schuster E, Braicu EI, et al
   Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
   Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34978.
   PubMed         Abstract available
   
   
8. HOLY P, Hlavac V, Seborova K, Susova S, et al
   Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression.
   Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34908.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

9. SHIM SH, Yang EJ, Jang EB, Lee S, et al
   Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study.
   Int J Gynaecol Obstet. 2024 Apr 29. doi: 10.1002/ijgo.15533.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

10. NAN Y, Wu X, Luo Q, Chang W, et al
    OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
    Proc Natl Acad Sci U S A. 2024;121:e2315348121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.